Abstract
A set of 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one-resveratrol antitumor hybrids were designed, synthesized, and evaluated. MTT results revealed that some of them exhibited significant antiproliferative activity on four selected tumor cell lines (i.e., HepG2, SK-OV-3, NCI-H460, and BEL-7404), while all these compounds displayed no cytotoxicity on HL-7702 normal liver cell line. NCI-H460 xenograft mouse assay results indicated that one representative hybrid showed potent antineoplastic effect and no obvious toxic effects and thus could be used as anticancer drug candidates. Further investigations revealed that this hybrid displayed potent antioxidant effect in mice, which may be related to its antitumor effect. This work suggests that rational design of 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one-resveratrol hybrids as antitumor agent is feasible.
Graphical abstract
Similar content being viewed by others
References
Saiko P, Szakmary A, Jaeger W, Szekere T (2008) Mutat Res-Rev Mutat 658:68
Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, De Cabo R, Sinclair DA (2006) Nature 444:337
Lastra CA, Villegas I (2007) Biochem Soc T 35:1156
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Science 275:218
Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Anticancer Res 24:2783
Delmas D, Lancon A, Colin D, Jannin B, Latruffe N (2006) Curr Drug Targets 7:423
Huang C, Ma WY, Goranson A, Dong Z (1999) Carcinogenesis 20:237−242
Yu YC, Kuang WB, Huang RZ, Fang YL, Zhang Y, Chen ZF, Ma XL (2017) MedChemComm 8:1158
Baur JA, Sinclair DA (2006) Nat Rev Drug Discov 5:493
Oberley LW, Bueftner GR (1979) Cancer Res 39:1141
Huang XF, Ruan BF, Wang XT, Xu C, Ge HM, Tan RX (2007) Eur J Med Chem 42:263
Elangovan S, Neumann J, Sortais JB, Junge K, Darcel C, Beller M (2016) Nature Commun 7:12641
Szekeres T, Fritzer-Szekeres M, Saiko P, Jäger W (2010) Pharm Res 27:1042
Matos MJ, Mura F, Vazquez-Rodriguez S, Borges F, Santana L, Uriarte E, Olea-Azar C (2015) Molecules 20:3290
Hernandez C, Moreno G, Herrera RA, Cardona GW (2021) Molecules 26:2661
Micale N, Molonia MS, Citarella A, Cimino F, Saija A, Cristani M, Speciale A (2021) Molecules 26:4665
Zhang Y, Fang YL, Liang H, Wang HS, Hu K, Liu XX, Yi XH, Peng Y (2013) Bioorg Med Chem Lett 23:107
Zhou R, Skibo EB (1996) J Med Chem 39:4321
El-Gohary NS, Shaaban MI (2017) Eur J Med Chem 137:439
Perwez-Hussain S, Hofseth LJ, Harris CC (2003) Nat Res Cancer 3:276
Kuang WB, Huang RZ, Qin JL, Lu X, Qin QP, Zou BQ, Chen ZF, Liang H, Zhang Y (2018) Eur J Med Chem 157:139
Lee YL, Yen MT, Mau JL (2007) Food Chem 104:1
Oi N, Jeong CH, Nadas J, Cho YY, Pugliese A, Bode AM, Dong ZG (2010) Cancer Res 70:9755
Acknowledgements
This study was supported by the Guangxi Natural Science Foundation (Nos. 2020GXNSFFA325001 and 2020GXNSFAA297167), National Natural Science Foundation of China (Nos. 82160657 and 82104008), Scientific Research Project of Hebei Provincial Administration of Traditional Chinese Medicine (2015078), Guangxi New Century Ten, Hundred and Thousand Talents Project ([2017]42) and Guangxi Key Laboratory of Agricultural Resources Chemistry and Biotechnology (2019KF02).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Guo, H., Qin, JL., Kuang, WB. et al. Design, synthesis, antioxidant and antitumor activity of some 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one-resveratrol hybrids. Monatsh Chem 154, 131–140 (2023). https://doi.org/10.1007/s00706-022-02994-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-022-02994-w